Archives
-
(S)-(+)-Methoprene for Juvenile Hormone Assays
2026-09-10
Use (S)-(+)-Methoprene as a controlled juvenile hormone analog to separate receptor-level signaling from endogenous hormone biosynthesis. This workflow connects transcription factor Met activation with larval maintenance, vitellogenesis, ovarian development, and comparative endocrine toxicology.
-
SW033291: 15-PGDH Inhibitor Workflows
2026-09-10
SW033291 connects nanomolar 15-PGDH inhibition with measurable prostaglandin E2 elevation, hematopoietic signaling, and regenerative phenotypes. This practical guide separates direct enzyme activity from cell and tissue outcomes, helping researchers design stronger hematopoiesis, muscle repair, and tissue regeneration studies.
-
JAK Inhibitors and Endothelial Vascular Responses
2026-09-09
A 2025 comparative study shows that approved JAK inhibitors consistently reduce cytokine-induced endothelial IL-6, but differ substantially in their effects on IL-8, adhesion molecules, tissue factor, thrombomodulin, and apoptosis. The findings argue that anti-inflammatory activity alone is not a sufficient indicator of vascular safety and provide a framework for interpreting endothelial responses in inflammatory disorder research.
-
MK 0893: From GCGR Binding to Translation
2026-09-09
MK 0893 is a glucagon receptor antagonist that connects allosteric receptor pharmacology with cellular cAMP assays and translational glucose studies. This article explains how to interpret its mechanism, selectivity, formulation, and in vivo evidence without confusing receptor potency with metabolic efficacy.
-
Pentoxifylline and Preterm Monocyte Hyperinflammation
2026-09-08
This study established an in vitro whole-blood model showing that pentoxifylline suppresses LPS-induced inflammatory activation in monocytes from preterm and term infants, with particularly strong effects on selected surface markers in preterm cells. Its integrated analysis of phenotype, cytokines, phagocytosis, and TLR4 expression provides a useful framework for evaluating age-dependent immunomodulation while highlighting the limits of translating neonatal in vitro findings directly to therapy.
-
1-Phenyl-2-Pentanol and Liver Fibrosis
2026-09-07
The reference study identifies 1-phenyl-2-pentanol from Moringa oleifera leaves as an inhibitor of profibrotic activation in TGF-β1-stimulated human hepatic stellate cells. Its combination of gene and protein measurements, proteomics, and molecular docking connects reduced extracellular-matrix markers with modulation of TGF-β1 and Wnt/β-catenin signaling, while also defining important limits for translation beyond cell culture.
-
PP2A, Autophagy, and Candida Biofilm Resistance
2026-09-07
Shen et al. show that protein phosphatase 2A, encoded in part by PPH21, links Atg13 phosphorylation and Atg1 activation to autophagy, Candida albicans biofilm formation, and antifungal resistance. The study combines genetic, pharmacological, cellular, and murine oral-infection evidence, identifying PP2A-regulated autophagy as a mechanistic determinant of treatment response.
-
FDA-Approved Drugs Against MERS-CoV: de Wilde et al.
2026-09-05
The reference study used a phenotypic screen of FDA-approved compounds to identify four agents that inhibited MERS-CoV replication in cell culture, including Lopinavir. Its main contribution was to show how drug repurposing can rapidly generate antiviral leads while also clarifying why cell-based potency requires careful validation before clinical or in vivo interpretation.
-
Rifampin Workflows for Bacterial Transcription
2026-09-05
Rifampin provides a practical, target-focused way to interrupt bacterial transcription while separating RNA-level effects from slower growth and viability changes. This guide turns its rifamycin antibiotic mechanism into reproducible workflows for resistance studies, transcriptional regulation, synthetic biology, and antibiotic drug research.
-
Phosbind Biotin for Reliable Phosphorylation Analysis
2026-09-04
This scenario-driven guide explains how Phos binding reagent (Phosbind) Biotin, SKU F4001, can complement viability, proliferation, and cytotoxicity assays by providing sequence-independent Western Blot detection of phosphorylated proteins. It covers assay interpretation, membrane workflow, handling constraints, and practical vendor-selection criteria.
-
Roscovitine: Designing Mechanistic CDK Assays
2026-09-04
Roscovitine, also known as Seliciclib, can serve as a mechanistic anchor for interpreting CDK-driven phenotypes. This article connects its reversible cell-cycle activity with data-driven small-molecule library design and practical assay-selection decisions.
-
Lithium, Exosomal Wnt10a, and Bone Regeneration
2026-09-03
A 2024 ACS Applied Materials & Interfaces study identifies a Rab11a–Rab11FIP1 trafficking mechanism through which lithium increases exosomal Wnt10a release from bone mesenchymal stem cells and activates β-catenin signaling. The findings support lithium-engineered exosomes and GelMA hydrogels as preclinical strategies for improving osteogenesis and bone repair.
-
Firefly Luciferase mRNA: Applied Workflow Guide
2026-09-02
Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) provides a sensitive, non-destructive way to compare transfection, translation, delivery, and viability-related signals. This practical guide connects routine reporter assays with repeated-dose LNP research while emphasizing controls, normalization, and troubleshooting.
-
RNA Pol II Loss Activates Apoptosis Beyond Transcription
2026-09-02
Harper et al. (2025) show that RNA polymerase II inhibition induces programmed cell death through loss of hypophosphorylated RNA Pol IIA, rather than through transcriptional shutdown alone. Their identification of the Pol II degradation-dependent apoptotic response (PDAR) provides a framework for interpreting transcription-targeting drugs and designing mechanistic apoptosis studies.
-
circ_0042103/TAF15/NER Axis in Pulpitis
2026-09-02
The reference study identifies a circ_0042103–TAF15–NER regulatory axis that links DNA damage with inflammatory progression in dental pulp stem cells. Its combined tissue, single-cell, molecular-interaction, and perturbation data provide a mechanistic framework for studying circular RNA control of pulpitis, while also highlighting the need for independent circRNA validation and repair-function assays.